EUCTR2016-001591-30-DK进行中（未招募）1 期
Treatment of congenital nephrogenic diabetes insipidus with a guanylate cyclase stimulator, riociguat or a phosphodiesterase type 5 inhibitor, sildenafil
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Age > 18 year
- •- Mentally capable of understanding the test
- •- Nephrogenic diabetes insipidus
- •- Followed at the Odense University Hospital
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 2
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Other known relevant disease including malignity
- •- Contraindications to riociguat or sildenafil (e.g. treatment with nitrovasodilators).
- •- Systolic blood pressure < 95mmHg
研究者
相似试验
进行中（未招募）
1 期
Treatment of the genetic disease nephrogenic diabetes insipidus with the antifungal drug Fluconazoleephrogenic diabetes insipidusMedDRA version: 21.0Level: LLTClassification code 10012600Term: Diabetes insipidus nephrogenicSystem Organ Class: 100000004857EUCTR2020-002204-38-DKClaus Bistrup10
尚未招募
2 期
Ayurvedic management of Diabetic Nephropathy (stage 1 and 2)CTRI/2022/09/045629All India Institue Of Ayurveda
已完成
3 期
Initial treatment of idiopathic nephrotic syndrome in children with mycophenolate mofetil vs. prednisone: A randomized, controlled, multicenter studyN04.9DRKS00006547niversitätsklinikum Heidelberg272
进行中（未招募）
1 期
Initial treatment of nephrotic syndrome in childreEUCTR2014-001991-76-DERuprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial340
招募中
2 期
Establishment of therapeutic strategy for renal cell carcinoma based on the evaluation by FDG PET/CTadvanced renal cell carcinomaJPRN-UMIN000008141Yokohama City University80